•
Sep 30, 2021

iTeos Therapeutics Q3 2021 Earnings Report

Total Revenue
$104M
EPS
$1.86
Previous year: -$0.48
-487.5%
Gross Profit
$104M
Cash and Equivalents
$900M
Previous year: $340M
+164.6%
Free Cash Flow
$604M
Previous year: -$10.3M
-5949.3%
Total Assets
$922M
Previous year: $351M
+162.8%

iTeos Therapeutics

iTeos Therapeutics